Detalhe da pesquisa
1.
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
Nature
; 561(7724): 479-484, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258136
2.
Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study.
AIDS Care
; 34(6): 698-707, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896276
3.
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.
AIDS Res Ther
; 18(1): 58, 2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496848
4.
Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study.
Infection
; 46(3): 341-347, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460228
5.
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
JAMA
; 316(2): 171-81, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404185
6.
Dynamics and durability of HIV-1 neutralization are determined by viral replication.
Nat Med
; 29(11): 2763-2774, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957379
7.
Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study.
J Antimicrob Chemother
; 72(9): 2679-2681, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859438
8.
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial.
Lancet Microbe
; 3(3): e203-e214, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544074
9.
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
HIV Res Clin Pract
; 23(1): 15-21, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234092
10.
Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany.
Liver Int
; 30(8): 1169-72, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20633101
11.
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
Open Forum Infect Dis
; 7(9): ofaa356, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965277
12.
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals.
Nat Med
; 23(2): 185-191, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28092665
13.
Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
Antivir Ther
; 11(8): 1097-101, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17302380
14.
Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection.
Expert Opin Investig Drugs
; 18(11): 1773-85, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19888873
15.
Anidulafungin--state of affairs from a clinical perspective.
Mycoses
; 50 Suppl 1: 38-43, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17394608